Determination of azithromycin heteroresistant Campylobacter jejuni in traveler’s diarrhea

Abstract Campylobacter is the most common cause of traveler’s diarrhea (TD) and human bacterial gastroenteritis. A heteroresistant Campylobacter jejuni (C. jejuni) isolate, identified by microbiological methods and characterized with molecular techniques, was obtained from a traveler in Nepal suffer...

Full description

Bibliographic Details
Main Authors: Woradee Lurchachaiwong, Supaporn Ruksasiri, Patcharawalai Wassanarungroj, Oralak Serichantalergs, Ladaporn Bodhidatta, John Crawford, Sanjaya Kumar Shrestha, Prativa Pandey
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Gut Pathogens
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13099-019-0301-1
_version_ 1818109312563675136
author Woradee Lurchachaiwong
Supaporn Ruksasiri
Patcharawalai Wassanarungroj
Oralak Serichantalergs
Ladaporn Bodhidatta
John Crawford
Sanjaya Kumar Shrestha
Prativa Pandey
author_facet Woradee Lurchachaiwong
Supaporn Ruksasiri
Patcharawalai Wassanarungroj
Oralak Serichantalergs
Ladaporn Bodhidatta
John Crawford
Sanjaya Kumar Shrestha
Prativa Pandey
author_sort Woradee Lurchachaiwong
collection DOAJ
description Abstract Campylobacter is the most common cause of traveler’s diarrhea (TD) and human bacterial gastroenteritis. A heteroresistant Campylobacter jejuni (C. jejuni) isolate, identified by microbiological methods and characterized with molecular techniques, was obtained from a traveler in Nepal suffering TD. The presence of atypical colonies within the clear zone of inhibition was the first evidence of an atypical phenotype, leading to additional characterization of this heteroresistant strain. Antimicrobial susceptibility testing (AST) and population analysis profiling (PAP) demonstrated heteroresistance to azithromycin (AZM), a first-line antibiotic treatment for Campylobacter infections. Molecular analysis indicated a point mutation occurred on the 23S rRNA gene at the A2075G transitions, and the number of mutated gene copies was proportional to AZM resistance. Heteroresistant C. jejuni subpopulations from acute TD are likely underestimated, which may lead to treatment failures, as was the case for this patient. The presence of a heteroresistant strain in a high antibiotic environment may select for additional drug resistance and enable distribution into hospital and local communities.
first_indexed 2024-12-11T02:29:15Z
format Article
id doaj.art-776132ba230144cb86bdbe2dd022bb2b
institution Directory Open Access Journal
issn 1757-4749
language English
last_indexed 2024-12-11T02:29:15Z
publishDate 2019-05-01
publisher BMC
record_format Article
series Gut Pathogens
spelling doaj.art-776132ba230144cb86bdbe2dd022bb2b2022-12-22T01:23:52ZengBMCGut Pathogens1757-47492019-05-011111510.1186/s13099-019-0301-1Determination of azithromycin heteroresistant Campylobacter jejuni in traveler’s diarrheaWoradee Lurchachaiwong0Supaporn Ruksasiri1Patcharawalai Wassanarungroj2Oralak Serichantalergs3Ladaporn Bodhidatta4John Crawford5Sanjaya Kumar Shrestha6Prativa Pandey7Department of Bacterial and Parasitic Diseases, Armed Forces Research Institute of Medical SciencesDepartment of Bacterial and Parasitic Diseases, Armed Forces Research Institute of Medical SciencesDepartment of Bacterial and Parasitic Diseases, Armed Forces Research Institute of Medical SciencesDepartment of Bacterial and Parasitic Diseases, Armed Forces Research Institute of Medical SciencesDepartment of Bacterial and Parasitic Diseases, Armed Forces Research Institute of Medical SciencesDepartment of Bacterial and Parasitic Diseases, Armed Forces Research Institute of Medical SciencesWalter Reed AFRIMS Research UnitCIWEC Clinic Travel Medicine CenterAbstract Campylobacter is the most common cause of traveler’s diarrhea (TD) and human bacterial gastroenteritis. A heteroresistant Campylobacter jejuni (C. jejuni) isolate, identified by microbiological methods and characterized with molecular techniques, was obtained from a traveler in Nepal suffering TD. The presence of atypical colonies within the clear zone of inhibition was the first evidence of an atypical phenotype, leading to additional characterization of this heteroresistant strain. Antimicrobial susceptibility testing (AST) and population analysis profiling (PAP) demonstrated heteroresistance to azithromycin (AZM), a first-line antibiotic treatment for Campylobacter infections. Molecular analysis indicated a point mutation occurred on the 23S rRNA gene at the A2075G transitions, and the number of mutated gene copies was proportional to AZM resistance. Heteroresistant C. jejuni subpopulations from acute TD are likely underestimated, which may lead to treatment failures, as was the case for this patient. The presence of a heteroresistant strain in a high antibiotic environment may select for additional drug resistance and enable distribution into hospital and local communities.http://link.springer.com/article/10.1186/s13099-019-0301-1HeteroresistanceCampylobacter jejuniAzithromycinTravelers
spellingShingle Woradee Lurchachaiwong
Supaporn Ruksasiri
Patcharawalai Wassanarungroj
Oralak Serichantalergs
Ladaporn Bodhidatta
John Crawford
Sanjaya Kumar Shrestha
Prativa Pandey
Determination of azithromycin heteroresistant Campylobacter jejuni in traveler’s diarrhea
Gut Pathogens
Heteroresistance
Campylobacter jejuni
Azithromycin
Travelers
title Determination of azithromycin heteroresistant Campylobacter jejuni in traveler’s diarrhea
title_full Determination of azithromycin heteroresistant Campylobacter jejuni in traveler’s diarrhea
title_fullStr Determination of azithromycin heteroresistant Campylobacter jejuni in traveler’s diarrhea
title_full_unstemmed Determination of azithromycin heteroresistant Campylobacter jejuni in traveler’s diarrhea
title_short Determination of azithromycin heteroresistant Campylobacter jejuni in traveler’s diarrhea
title_sort determination of azithromycin heteroresistant campylobacter jejuni in traveler s diarrhea
topic Heteroresistance
Campylobacter jejuni
Azithromycin
Travelers
url http://link.springer.com/article/10.1186/s13099-019-0301-1
work_keys_str_mv AT woradeelurchachaiwong determinationofazithromycinheteroresistantcampylobacterjejuniintravelersdiarrhea
AT supapornruksasiri determinationofazithromycinheteroresistantcampylobacterjejuniintravelersdiarrhea
AT patcharawalaiwassanarungroj determinationofazithromycinheteroresistantcampylobacterjejuniintravelersdiarrhea
AT oralakserichantalergs determinationofazithromycinheteroresistantcampylobacterjejuniintravelersdiarrhea
AT ladapornbodhidatta determinationofazithromycinheteroresistantcampylobacterjejuniintravelersdiarrhea
AT johncrawford determinationofazithromycinheteroresistantcampylobacterjejuniintravelersdiarrhea
AT sanjayakumarshrestha determinationofazithromycinheteroresistantcampylobacterjejuniintravelersdiarrhea
AT prativapandey determinationofazithromycinheteroresistantcampylobacterjejuniintravelersdiarrhea